首页|基于代谢组学探讨首荟通便胶囊对脑缺血再灌注模型大鼠的保护作用及机制研究

基于代谢组学探讨首荟通便胶囊对脑缺血再灌注模型大鼠的保护作用及机制研究

扫码查看
探讨首荟通便胶囊(SHTB)对大鼠脑缺血再灌注模型的保护作用及潜在机制。将大鼠随机分为假手术组、模型组、首荟通便胶囊低剂量组(0。2 g·kg-1·d-1)、首荟通便胶囊高剂量组(0。4g·kg-1·d-1)、依达拉奉阳性药组(5。4 mg·kg-1·d-1),每组12只。大鼠于术前7 d连续灌胃给药,使用线栓法建立大鼠脑缺血再灌注损伤(cerebral ischemia-reperfusion injury,CIRI)模型。通过Zea-Longa等级神经功能评分表评定大鼠神经功能受损情况;苏木素-伊红(HE)染色观察大鼠脑组织病理损伤情况;2,3,5-氯化三苯基四氮唑(TTC)染色测定大鼠脑梗死面积;酶联免疫吸附测定(enzyme-linked immunosorbent assay,ELISA)试剂盒检测各组大鼠血清白细胞介素-6(interleukin-6,IL-6)、白细胞介素-1β(interleukin-1β,IL-1β)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)的水平;蛋白免疫印记(Western blot)技术检测大鼠血脑屏障以及肠道屏障相关紧密连接蛋白水平和脑组织Toll样受体4(Toll-like receptor 4,TLR4)/髓样分化因子88(myeloid differentiation factor 88,MyD88)/核因子κB(nuclear factor-κB,NF-κB)通路相关蛋白表达;超高效液相色谱-串联质谱(UPLC-MS/MS)检测大鼠脑组织和血清代谢物的变化,挖掘出SHTB治疗大鼠脑缺血再灌注损伤的潜在机制。与模型组相比,SHTB可明显缓解脑缺血再灌注损伤(cerebral ischemia/reperfusion injury,CIRI)大鼠脑部病理损伤,减少脑梗体积,降低血清中炎症水平;Western blot结果显示,与模型组相比,SHTB能够调控CIRI大鼠血脑屏障及肠道屏障相关紧密连接蛋白的表达,下调脑组织TLR4、NF-κB、MyD88蛋白表达;UPLC-MS/MS结果表明,SHTB可显著调节脂肪酸类等潜在差异代谢物的含量,血清与脑组织的共有通路涉及不饱和脂肪酸生物合成等通路。SHTB可修复肠道屏障功能,降低机体炎症水平,进而改善受损的血脑屏障,发挥保护脑神经的作用,其机制可能是通过平衡脂肪酸代谢,调节TLR4/MyD88/NF-κB信号通路蛋白的表达来实现。
Study on protective effect and mechanism of Shouhui Tongbian Capsules on cerebral ischemia-reperfusion rat models based on metabolomics
This paper explored the protective effect and potential mechanism of Shouhui Tongbian Capsules (SHTB) on cerebral ischemia-reperfusion rat models.Rats were randomly divided into sham surgery group,model group,low-dose SHTB group (0.2 g·kg-1·d-1),high-dose SHTB group (SHTB g·kg-1·d-1),and an edaravone positive drug group (5.4 mg·kg-1·d-1),with 12 rats in each group.Rats were given continuous intragastric administration seven days before surgery,and the suture method was used to establish the cerebral ischemia-reperfusion injury (CIRI) rat model.Zea-Longa rating scale for neurological functions was used to assess the degree of neurological function impairment in rats;hematoxylin-eosin (HE) staining was used to observe the pathological damage of rats' brain tissue;TTC staining was used to measure the area of cerebral infarction in rats;enzyme-linked immunosorbent assay (ELISA) was used to detect the serum levels of interleukin-6 (IL-6),interleukin-1β (IL-1β),and tumor necrosis factor-α (TNF-α) in each group.Western blot was used to detect the level of tight junction protein associated with the blood-brain barrier and intestinal barrier,as well as the protein expression of the TLR4/MyD88/NF-κB pathway in brain tissue.Changes in rats' brain tissue and metabolites in serum were detected by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS),so as to explore the potential mechanism of SHTB treatment for CIRI in rats.Compared with the model group,SHTB could significantly alleviate the pathological damage to the brain of CIRI rats,reduce the volume of cerebral infarction,and lower the level of inflammation in the serum;Western blot results showed that SHTB could regulate the expression of tight junction proteins related to the blood-brain barrier and intestinal barrier in CIRI rats and downregulate the expression of TLR4,NF-κB,and MyD88 proteins in brain tissue.The UPLC-MS/MS results indicated that SHTB could significantly regulate the content of potential differential metabolites such as fatty acids,and serum and brain tissue are involved in pathways such as unsaturated fatty acid biosynthesis.SHTB could repair intestinal barrier function,reduce inflammation levels in the body,and improve the damaged blood-brain barrier,exerting a protective effect on brain nerves.Its mechanism may be achieved by balancing fatty acid metabolism and regulating the expression of TLR4/MyD88/NF-κB signaling pathway proteins.

Shouhui Tongbian Capsulescerebral ischemia-reperfusionblood-brain barrierintestinal barrierinflammationmetabolomics

韦方娇、张丛慧、王秀文、汪琨、王志康、姚景春、张贵民

展开 >

山东中医药大学药学院,山东济南 250355

临沂市天然药物免疫药理毒理重点实验室,山东临沂 273400

鲁南制药集团股份有限公司经方与现代中药融合创新全国重点实验室,山东临沂 273400

首荟通便胶囊 脑缺血再灌注 血脑屏障 肠道屏障 炎症 代谢组学

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(24)